Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO

Watchlist Manager
Indraprastha Medical Corporation Ltd Logo
Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
Watchlist
Price: 399.35 INR -1.94% Market Closed
Market Cap: 36.6B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+51%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

INDRAMEDCO Price Targets Summary
Indraprastha Medical Corporation Ltd

Wall Street analysts forecast INDRAMEDCO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INDRAMEDCO is 601.8 INR with a low forecast of 595.9 INR and a high forecast of 619.5 INR.

INDRAMEDCO Lowest Forecast
Wall Street Target
595.9 INR
49% Upside
INDRAMEDCO Average Forecast
Wall Street Target
601.8 INR
51% Upside
INDRAMEDCO Highest Forecast
Wall Street Target
619.5 INR
55% Upside
Lowest
Price Target
595.9 INR
49% Upside
Average
Price Target
601.8 INR
51% Upside
Highest
Price Target
619.5 INR
55% Upside
Indraprastha Medical Corporation Ltd Competitors:
Price Targets
4004
Dallah Healthcare Company SJSC
5% Downside
B
BDMS
Bangkok Dusit Medical Services PCL
56% Upside
MEDICAB
Medica Sur SAB de CV
68% Upside
P
PHG
Patrangsit Healthcare Group PCL
56% Upside
4004
Dallah Healthcare Company SJSC
5% Downside
B
BDMS
Bangkok Dusit Medical Services PCL
56% Upside
MEDICAB
Medica Sur SAB de CV
68% Upside
P
PHG
Patrangsit Healthcare Group PCL
56% Upside
BH
Bumrungrad Hospital PCL
65% Upside
G
GPTHEALTH
GPT Healthcare Ltd
10% Upside
JYNT
Joint Corp
40% Upside
A50
Thomson Medical Group Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Indraprastha Medical Corporation Ltd

For the last 13 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's revenue is 8%. The projected CAGR for the next 2 years is 9%.

8%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Indraprastha Medical Corporation Ltd

For the last 13 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's operating income is 12%. The projected CAGR for the next 5 years is -14%.

12%
Past Growth
-14%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Indraprastha Medical Corporation Ltd

For the last 13 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's net income is 15%. The projected CAGR for the next 2 years is 14%.

15%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

See Also

Summary
INDRAMEDCO intrinsic value, competitors valuation, and company profile.
DCF Valuation
INDRAMEDCO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INDRAMEDCO stock valuation using valuation multiples.
Wall Street Estimates
INDRAMEDCO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INDRAMEDCO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INDRAMEDCO's stock price target?
Price Target
601.8 INR

According to Wall Street analysts, the average 1-year price target for INDRAMEDCO is 601.8 INR with a low forecast of 595.9 INR and a high forecast of 619.5 INR.

What is Indraprastha Medical Corporation Ltd's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's revenue is 8%. The projected CAGR for the next 2 years is 9%.

What is Indraprastha Medical Corporation Ltd's Operating Income forecast?
Projected CAGR
-14%

For the last 13 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's operating income is 12%. The projected CAGR for the next 5 years is -14%.

What is Indraprastha Medical Corporation Ltd's Net Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's net income is 15%. The projected CAGR for the next 2 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.